Drugs / Budesonide/formoterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06027606 | Sep 2023 → Sep 2025 | — | University of Alberta | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06027606 ↗ |
| Route | Inhaled | “Use an inhaler for 4 weeks” NCT06027606 ↗ |